Subscribe To
hillevax to present at upcoming investor conferences
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceut...
November 1, 2023, 4:48 pm
hillevax to participate in fireside chat at the 2023 cantor global healthcare conference
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceu...
September 26, 2023, 4:01 pm
hillevax announces pricing of public offering of common stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmace...
September 20, 2023, 12:05 am
hillevax: takeda's norovirus vaccine spinout
hillevax is developing a virus-like particle vaccine candidate, HIL-214, for norovirus-induced acute ga...
August 30, 2023, 7:32 pm
Wall street analysts predict a 56.76% upside in hillevax, inc. (hlvx): here's what you should know
The average of price targets set by Wall Street analysts indicates a potential upside of 56.8% in hillevax...
June 7, 2023, 11:03 am
hillevax reports first quarter 2023 financial results and highlights recent company progress
BOSTON, May 12, 2023 (GLOBE NEWSWIRE) — hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceut...
May 12, 2023, 8:05 pm
After plunging 32.4% in 4 weeks, here's why the trend might reverse for hillevax, inc. (hlvx)
hillevax, Inc. (HLVX) is technically in oversold territory now, so the heavy selling pressure might hav...
December 14, 2022, 11:17 am
Down 25.2% in 4 weeks, here's why you should you buy the dip in hillevax, inc. (hlvx)
hillevax, Inc. (HLVX) has become technically an oversold stock now, which implies exhaustion of the hea...
December 13, 2022, 11:17 am
hillevax announces positive immunogenicity results for run-in cohort of nest-in1 phase 2b clinical trial of hil-214 norovirus vaccine candidate
BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) — hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceu...
December 5, 2022, 11:30 am
Here's why "trend" investors would love betting on hillevax, inc. (hlvx)
hillevax, Inc. (HLVX) could be a great choice for investors looking to make a profit from fundamentally...
November 18, 2022, 9:55 am
hillevax to participate in november investor conferences
BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceut...
November 10, 2022, 6:30 pm
hillevax to participate in j.p. morgan biotech – 2022 conference call series
BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- hillevax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceu...
September 1, 2022, 5:18 pm